To develop products and services concerning the emissions of human and veterinary pharmaceuticals and multi-resistant bacteria in soil, food, water and air, and, at the same, supports the regional economy. The project focuses on the cross-border catchment of the Vechte River as a case study and aims at increasing cross-border innovation in the program area.
1) Measurement, visualization, and communication of the problem, 2) Simulating action, 3) Mitigation and prevention.
- Medicine Unwanted in Water (MEDUWA)
- Modelling environmental antibiotic-resistance gene abundance: A meta-analysis
- Oxidative degradation of cyclophosphamide using thermal plasma activation and UV/H2O2 treatment in tap water
- Alternative societal solutions to pharmaceuticals in the aquatic environment
- MEDicines Unwanted in WAter, MEDUWA-Vecht(e)
- MEDUWA Declaration 2020 on the Emission of Human & Veterinary Medicines
- Green medicines – utopia or option?
- The grey water footprint of human and veterinary pharmaceuticals
HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.